Investigation of the onset of pregnancy and changes during subsequent outcomes in the background of administration of cyclophosphamide and doxorubicin to female white rats
https://doi.org/10.25789/YMJ.2025.91.08
Abstract
The article presents information about a scientific study conducted to study changes in the course of pregnancy and its outcomes after administration of cyclophosphamide and doxorubicin to female white rats for therapeutic purposes. Women taking antitumor drugs from the cytostatic group may become pregnant during treatment. Given the conflicting opinions about the effect of these drugs on pregnant women and the fetus, it was determined how the therapeutic use of cyclophosphamide and doxorubicin, which are representatives of the cytostatic group, individually and in combination, depending on the dose, affects the onset, course of pregnancy and fetal development in the prenatal and early postnatal periods. Since cytostatics, when used together, cause a sharp decrease in the amount of sex hormones, no pregnancies have been observed against the background of their use. The results of our studies show that compared with the use of a dose of 2.5 mg/ kg of doxorubicin and a dose of 10 mg/ kg of cyclophosphamide, cyclophosphamide has a stronger effective, teratogenic effect.
References
1. Obstetrics and Gynecology. 4th ed., revised and additional Clinical recommendations. Savelyeva G.M., Serov V.N., Sukhov G.T., ed. M.: GEOTAR-Media; 2020, 1008. https://doi.org/10.29001/2073-8552-2024-39-4-171-179.
2. The effect of pyrimidine and 3-hydroxypyridine derivatives in liposomes on erythrocytopoiesis parameters using liposomal doxorubicin and cyclophosphamide in rats with malignant tumor process / Solovyova M.A., Siprov A.V., Ageev V.P. [et al.] // Modern problems of science and education. 2021. No. 2. URL: https://science-education.ru/ru/article/view?id=30594 (date of request: 22/08/2025). DOI: https://doi.org/10.17513/spno.30594
3. Comprehensive assessment of subchronic low-dose exposure to doxorubicin in the Wistar rat model / Asanov M.A., Poddubnyak A.O., Muhamadiyarov R.A. [et al.] // Siberian Journal of Clinical and Experimental Medicine. 2024;39(4):171–179. https://doi.org/10.29001/2073-8552-2024-39-4-171-179.
4. Bai Z, Wang Z. Genistein protects against doxorubicin-induced cardiotoxicity through Nrf2/HO-1 signaling in mice model. Environ Toxicol. 2019 May;34(5):645-651. doi: 10.1002/tox.22730.
5. Bosch E, Alviggi C, Lispi M, Conforti A, Hanyaloglu AC, Chuderland D, et al. Reduced FSH and LH action: implications for medically assisted reproduction. Hum Reprod. 2021 May 17;36(6):1469-1480. doi: 10.1093/humrep/deab065.
6. Campagne O, Zhong B, Nair S, Lin T, Huang J, Onar-Thomas A, Robinson G, Gajjar A, Stewart CF. Exposure-Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing. Clin Cancer Res. 2020 Apr 1;26(7):1563-1573. doi: 10.1158/1078-0432.CCR-19-2685.
7. Hirshman NA, Hughes FM Jr, Jin H, Harrison WT, White SW, Doan I, Harper SN, Leidig PD, Purves JT. Cyclophosphamide-induced cystitis results in NLRP3-mediated inflammation in the hippocampus and symptoms of depression in rats. Am J Physiol Renal Physiol. 2020 Feb 1;318(2):F354-F362. doi: 10.1152/ajprenal.00408.2019.
8. Huang L, Huang Z, Chen C. Rhythmic growth hormone secretion in physiological and pathological conditions: Lessons from rodent studies. Mol Cell Endocrinol. 2019 Dec 1;498:110575. doi: 10.1016/j.mce.2019.110575.
9. Ma ZG, Kong CY, Wu HM, Song P, Zhang X, Yuan YP, Deng W, Tang QZ. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice. Theranostics. 2020 Sep 2;10(24):11013-11025. doi: 10.7150/thno.47516.
10. Tabchi S, Nair R, Kunacheewa C, Patel KK, Lee HC, Thomas SK, et al. Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia. Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):560-569. doi: 10.1016/j.clml.2019.05.001
Review
For citations:
Heybatova M.F. Investigation of the onset of pregnancy and changes during subsequent outcomes in the background of administration of cyclophosphamide and doxorubicin to female white rats. Yakut Medical Journal. 2025;(3):36-39. (In Russ.) https://doi.org/10.25789/YMJ.2025.91.08
Views:
5
Email this article 